| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Irinotecan | gCSI | pan-cancer | AAC | 0.098 | 0.06 |
| mRNA | CIL70 | CTRPv2 | pan-cancer | AAC | 0.089 | 0.06 |
| mRNA | Gefitinib | CTRPv2 | pan-cancer | AAC | -0.069 | 0.06 |
| mRNA | indisulam | CTRPv2 | pan-cancer | AAC | 0.06 | 0.06 |
| mRNA | Methotrexate | CTRPv2 | pan-cancer | AAC | 0.069 | 0.06 |
| mRNA | CIL41 | CTRPv2 | pan-cancer | AAC | 0.096 | 0.06 |
| mRNA | YK 4-279 | CTRPv2 | pan-cancer | AAC | 0.059 | 0.07 |
| mRNA | Erlotinib | CTRPv2 | pan-cancer | AAC | -0.064 | 0.07 |
| mRNA | BIBR-1532 | CTRPv2 | pan-cancer | AAC | 0.067 | 0.07 |
| mRNA | RO4929097 | CTRPv2 | pan-cancer | AAC | -0.099 | 0.07 |